Faced with dramatic changes in the practice and financing of medicine during the past 2 decades, clinicians, educators, and researchers have struggled to adapt. Obstetrics and gynecology has seen an increased emphasis on subspecialization, without equal emphasis on enhancing women’s care.
Recent guidance issued by the U.S. Department of Health and Human Services (HHS) seeking to clarify patient safety work product (PSWP) privilege under the Patient Safety Act has instead stoked conflicting opinions among organizations representing healthcare providers as to how the provision should be interpreted.
Preventing drug shortages requires a “swat team” mentality by all, including FDA, manufacturers, group purchasing organizations (GPOs), and health systems. Here’s what healthcare providers should do about the issue.